Results 191 to 200 of about 48,910 (207)

Therapeutic options for carbapenem-resistant Enterobacteriaceae infections

Virulence, 2017
Enrico Trecarichi, Mario Tumbarello
exaly  

Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China

Clinical Microbiology and Infection, 2020
Xueqing Wu, Murat áková
exaly  

Changing epidemiology of carbapenem-resistant Enterobacteriaceae carriage during an outbreak of carbapenem-resistant Klebsiella pneumoniae

Journal of Hospital Infection, 2010
Y, Geffen, R, Finkelstein, I, Oren, R, Shalaginov, I, Tavleva, H, Sprecher   +5 more
openaire   +2 more sources

Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?

Virulence, 2017
Sandra S Richter
exaly  

Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States

Clinical Microbiology and Infection, 2017
Bruce Lee, B Y Lee
exaly  

Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae

Virulence, 2017
Romney Humphries, Ritu Banerjee
exaly  

Diversity of carbapenem resistance bacteria and identification of carbapenem resistance genes in marine environment

2018
Dewa A.P. Rasmika Dewi, Thomas, Torsten
openaire   +1 more source

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

Clinical Infectious Diseases, 2016
Liang Chen, Hung T Nguyen, Yohei Doi
exaly  

Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States

Expert Review of Anti-Infective Therapy, 2014
Alexander Kallen, Alice Guh, Brandi M Limbago   +2 more
exaly  

Carbapenem-Resistant Enterobacteriaceae

Amália Raiana Fonseca Lobato, Beatriz Lobato da Silva, Artur Silva, Danielle Murici Brasiliense, Rafael Azevedo Baraúna   +4 more
openaire   +1 more source